================================================================================
U.S. SECURITIES AND EXCHANGE COMMISSION
WASHINGTON, DC 20549
----------
FORM 12b-25
Notification of Late Filing
----------
|_| Form 10-KSB |_| Form 11-K |_| Form 20-F |X| Form 10-QSB |_| Form N-SAR
For Quarter Ended: September 30, 2006
Nothing in this Form shall be construed to imply that the Commission has
verified any information contained herein.
If the notification relates to a portion of the filing checked above, identify
the Item(s) to which the notification relates:
N/A
--------------------------------------------------------------------------------
PART I - REGISTRANT INFORMATION
--------------------------------------------------------------------------------
bioMETRX, Inc.
--------------
(Exact Name of Registrant as Specified in Charter)
500 North Broadway, Suite 204
Jericho, New York 11753
-------------------------------------
(Address of Principal Executive Office)
================================================================================
--------------------------------------------------------------------------------
PART II - RULES 12B-25 (B) AND (C)
--------------------------------------------------------------------------------
If the subject report could not be filed without unreasonable effort or expense
and the registrant seeks relief pursuant to Rule 12b-25(b), the following should
be completed. (Check box if appropriate)
(a) The reasons described in reasonable detail in Part III of this form
could not be eliminated without unreasonable effort or expense;
(b) The subject annual report or semi-annual report/portion thereof will
be filed on or before the fifteenth calendar day following the
|X| prescribed due date; or the subject quarterly report/portion thereof
will be filed on or before the fifth calendar day following the
prescribed due date; and
(c) The accountant's statement or other exhibit required by Rule
12b-25(c) has been attached if applicable.
--------------------------------------------------------------------------------
PART III - NARRATIVE
--------------------------------------------------------------------------------
State below in reasonable detail the reasons why the Form 10-KSB, 11-K, 20-F,
10-QSB or N-SAR or portion thereof could not be filed within the prescribed
time:
The Company is filing this Form 12b-25 because it was unable to complete
it's Form 10-QSB for the quarter ended September 30, 2006 on a timely basis
without unreasonable effort and expense.
--------------------------------------------------------------------------------
PART IV - OTHER INFORMATION
--------------------------------------------------------------------------------
(1) Name and telephone number of person to contact in regard to this
notification
Joel C. Schneider, Esq. (516) 228-8181
(2) Have all other periodic reports required (under Section 13 or 15(d) of the
Securities and Exchange Act of 1934 or Section 30 of the Investment
Company Act of 1940) during the preceding 12 months (or for such shorter
period that the registrant was required to file such reports) been filed?
If answer no, identify report(s).
|X| YES |_| NO
2
(3) Is it anticipated that any significant change in results of operations
from the corresponding period for the last fiscal year will be reflected
by the earnings statement to be included in the subject report or portion
thereof?
|_| YES |X| NO
If so, attach an explanation of the anticipated change, both narratively
and quantitatively, and; if appropriate, state the reasons why a
reasonable estimate of the results can not be made.
bioMETRX, Inc. has caused this notification to be signed on its behalf by
the undersigned thereunto duly authorized.
Dated: November 14, 2006 BIOMETRX, INC.
By: /s/ Mark Basile
------------------------------------
Mark Basile, CEO
--------------------------------------------------------------------------------
ATTENTION
Intentional misstatements or omissions of act constitute Federal Criminal
Violations (See 18 U.S.C. 1001).
3